Echinocandins for treating invasive candidiasis

Published on 08 Feb 2023
Last Updated on 08 Feb 2023

Guidance Recommendations

The Ministry of Health's Drug Advisory Committee has recommended:

• Anidulafungin 100 mg injection

in line with its registered indications for treating invasive candidiasis in view of favourable clinical and cost-effectiveness compared with other echinocandins.

Funding status

Anidulafungin 100 mg injection is recommended for inclusion on the MOH Standard Drug List (SDL) from 1 April 2023. 

Subsidy does not apply to micafungin 50 mg injection or caspofungin 50 mg and 70 mg injections.

Echinocandins for treating invasive candidiasis (Published 8 Feb 2023) [PDF, 101 KB]